Cognex Corporation
NASDAQ:CGNXHardware, Equipment & Parts
-$0.64 today
- Market cap
- $8.27B
- Beta
- 1.51
- P/E (TTM)
- 75.7
- EPS (TTM)
- $0.86
- Dividend yield
- 0.52%
Volume 1.61M
Average 2.14M
CGNX Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Cognex CorporationNASDAQ: CGNX
Accounts Receivables · Q2 FY2026 · quarter ended Jul 2026
Accounts receivables growth accelerates
Q2 FY2026 accounts receivables of $41.05M (cash outflow) rose 101.7% year over year, ahead of the +85.0% change in trailing-twelve-month accounts receivables. Sequentially, it rose 77.6% from the prior quarter.
Context
- Accounts receivables amounted to 1.5% of revenue in FY2025, down 2.0 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +101.7% holds above the trailing-twelve-month pace of +85.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (15.23M) USD
- Year-over-year change
- +52.6%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (15.23M) | +52.6% |
| FY2024 | 2024-12-31 | (32.13M) | -239.1% |
| FY2023 | 2023-12-31 | 23.09M | +339.0% |
| FY2022 | 2022-12-31 | 5.26M | +283.5% |
| FY2021 | 2021-12-31 | (2.87M) | — |
Accounts Receivables vs competitors
How CGNX compares with its peers on the latest reported figures
- CGNX's LTM Jul 2026 accounts receivables of $42.17M is the 3rd largest of the 5 companies compared; the peer median is $12.74M.
- Its year-over-year change of +85.0% is the 2nd highest of 5, against a peer median of -100.1%.
- Accounts receivables amounts to 3.9% of revenue for CGNX, versus a peer median of 3.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $313M | -468.2% | +98.3% | 5.4% | |
| LTM Sep 2026 | $47.16M | -45.0% | — | 1.2% | |
| LTM Jul 2026 | $42.17M | +85.0% | — | 3.9% | |
| LTM Oct 2026 | $24.99M | +887.1% | +5.5% | 2.3% | |
| LTM Mar 2026 | $480K | -155.2% | — | 30.9% | |
| Peer median (excluding CGNX) | $12.74M | -100.1% | +51.9% | 3.8% | |
Competitors are the stored peer set for CGNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 279.88M | 215.53M | 113.23M | 106.17M | 114.44M |
| Depreciation & Amortization | 20.28M | 19.62M | 21.88M | 32.69M | 30.79M |
| Deferred Income Tax | (3.12M) | (27.34M) | (19.78M) | (21.51M) | 40.15M |
| Stock-Based Compensation | 43.77M | 54.51M | 54.77M | 52.44M | 48.52M |
| Change in Working Capital | (34.01M) | (73.53M) | (67.72M) | (24.85M) | 1.75M |
| Accounts Receivables | (2.87M) | 5.26M | 23.09M | (32.13M) | (15.23M) |
| Inventory | (54.92M) | (48.93M) | 3.78M | 2.51M | 4.86M |
| Accounts Payables | 27.83M | (17.28M) | (13.74M) | 18.35M | 11.71M |
| Other Working Capital | (4.05M) | (12.58M) | (80.84M) | (13.58M) | 405K |
| Other Non-Cash Items | 7.26M | 54.63M | 10.53M | 4.13M | 9.87M |
| Operating Cash Flow | 314.07M | 243.41M | 112.92M | 149.08M | 245.51M |
| Capital Expenditures | (15.46M) | (19.67M) | (23.08M) | (15.04M) | (8.74M) |
| Acquisitions (Net) | 0 | (5.05M) | (257.06M) | (1.44M) | 6.7M |
| Purchases of Investments | (668.05M) | (233.72M) | (184.06M) | (850.85M) | (290.22M) |
| Sales of Investments | 430.97M | 253.98M | 496.46M | 828.38M | 320.12M |
| Other Investing Activities | 0 | 0 | 0 | (8K) | 156K |
| Investing Cash Flow | (252.54M) | (4.45M) | 32.27M | (38.97M) | 28.02M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | (445K) |
| Common Stock Repurchased | (161.65M) | (204.31M) | (79.79M) | (67.09M) | (151.23M) |
| Dividends Paid | (43.26M) | (45.92M) | (49.08M) | (52.33M) | (54.63M) |
| Other Financing Activities | 63.29M | 9.86M | 3.27M | 994K | (388K) |
| Financing Cash Flow | (141.62M) | (240.37M) | (125.61M) | (118.42M) | (206.69M) |
| Effect of Forex Changes | (2.82M) | (3.37M) | 1.7M | (8.25M) | 9.99M |
| Net Change in Cash | (82.91M) | (4.79M) | 21.28M | (16.56M) | 76.83M |
| Free Cash Flow | 298.61M | 223.74M | 89.84M | 134.04M | 236.77M |
Cognex Corporation
NASDAQ:CGNX
Intrinsic Alpha fair value
Locked
Current Price
$49.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.